Dashboard
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of 3.27% and Operating profit at 1.92%
- NET SALES(9M) At Rs 5.94 cr has Grown at -85.56%
- PAT(9M) At Rs -1.30 cr has Grown at -85.56%
Risky - Negative Operating Profits
28.74% of Promoter Shares are Pledged
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Capital Markets
INR 21 Cr (Micro Cap)
NA (Loss Making)
24
0.00%
1.29
-15.86%
0.83
Total Returns (Price + Dividend) 
Onelife Capital for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Onelife Capital Advisors Ltd is Rated Sell
Onelife Capital Advisors Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 December 2025, providing investors with the latest insights into the company's performance and outlook.
Read More
Onelife Capital Advisors Hits Upper Circuit Amid Strong Buying Pressure
Onelife Capital Advisors Ltd witnessed a significant surge in its share price on 23 Dec 2025, hitting the upper circuit limit as robust buying interest propelled the stock to its maximum daily gain. The micro-cap company operating in the capital markets sector recorded a 4.35% rise, outperforming its sector and broader market indices despite subdued trading volumes and a regulatory freeze on further transactions.
Read More
Onelife Capital Advisors Hits Lower Circuit Amid Heavy Selling Pressure
Onelife Capital Advisors Ltd, a micro-cap player in the capital markets sector, faced intense selling pressure on 18 Dec 2025, resulting in the stock hitting its lower circuit limit. The share price closed at ₹15.85, marking a maximum daily loss of 0.94%, underperforming both its sector and the broader Sensex index. This movement reflects a significant supply-demand imbalance and heightened investor caution.
Read More Announcements 
Intimation Of Cancellation Of Rights Issue Committee Meeting Under Regulation 29 And 30 Of SEBI (LODR) Regulations 2015 Scheduled On Tuesday 23Rd December 2025
23-Dec-2025 | Source : BSECancellation of Right issue committee meeting of the Company scheduled on 23/12/2025 due to non-receipt of in-principal approval from BSE and NSE and the said meeting will be held once approval is received from both the stock exchanges
Board Meeting Intimation for Intimation Of Right Issue Committee Meeting Rescheduled To Be Held On 23Rd December 2025
17-Dec-2025 | Source : BSEOnelife Capital Advisors Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/12/2025 inter alia to consider and approve With reference to our earlier intimation dated 12th December 2025 pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the Right issue Committee Meeting of the Company originally scheduled on 17th December 2025 has been rescheduled and will now be held on Tuesday 23rd December 2025 through Video Conferencing/Other Audio-Visual Means (VC/OAVM). The agenda of the meeting remains unchanged
Board Meeting Intimation for Intimation Of Right Issue Committee Meeting In Compliance With Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 On Wednesday 17Th December 2025.
12-Dec-2025 | Source : BSEOnelife Capital Advisors Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/12/2025 inter alia to consider and approve To consider discuss and decide various matters in connection with the Rights Issue including the specific terms of the Rights Issue
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Promoters
28.7356
Held by 0 Schemes
Held by 0 FIIs
Naig Prabhakar K (51.68%)
P S Kumaresan (1.55%)
43.28%
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is 354.12% vs -30.89% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is -786.27% vs -113.67% in Jun 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is -45.99% vs 179.49% in Sep 2024
Growth in half year ended Sep 2025 is 18.34% vs -833.33% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'24
YoY Growth in nine months ended Dec 2024 is 118.95% vs 49.51% in Dec 2023
YoY Growth in nine months ended Dec 2024 is -665.52% vs 8.66% in Dec 2023
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is -69.51% vs 733.33% in Mar 2024
YoY Growth in year ended Mar 2025 is -1,417.95% vs 115.73% in Mar 2024






